Page last updated: 2024-08-16

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and chromium

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with chromium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashok Kumar, R; Guha, G; Mathew, L; Rajkumar, V1
Fleming, GJ; McGinley, EL; Moran, GP1

Other Studies

2 other study(ies) available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and chromium

ArticleYear
Aqueous extract of Phyllanthus amarus inhibits chromium(VI)-induced toxicity in MDA-MB-435S cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2010, Volume: 48, Issue:1

    Topics: Antioxidants; Benzothiazoles; Biphenyl Compounds; Cell Line, Tumor; Chromatography, High Pressure Liquid; Chromium; Chromium Compounds; Coloring Agents; Dose-Response Relationship, Drug; Female; Ferric Compounds; Flavonoids; Free Radical Scavengers; Humans; Indicators and Reagents; Lipid Peroxidation; Oxidants; Oxidative Stress; Phenols; Phyllanthus; Picrates; Plant Extracts; Sulfonic Acids; Tetrazolium Salts

2010
Development of a discriminatory biocompatibility testing model for non-precious dental casting alloys.
    Dental materials : official publication of the Academy of Dental Materials, 2011, Volume: 27, Issue:12

    Topics: Biocompatible Materials; Cell Count; Cell Death; Cell Line; Cell Shape; Cell Survival; Chromium; Chromium Alloys; Coloring Agents; Cytokines; Dental Casting Investment; Dinoprostone; Humans; Indicators and Reagents; Interleukin-1alpha; Interleukin-8; Keratinocytes; L-Lactate Dehydrogenase; Materials Testing; Nickel; Spectrophotometry, Atomic; Surface Properties; Tetrazolium Salts; Trypan Blue; Tumor Necrosis Factor-alpha

2011